Regeneron capital expenditures surpass $600 million in race to add factory, lab space

In an annual report filed this week, Regeneron forecasted capital spending of $600 million to $680 million in 2021. That money primarily will stay in New York as the company continues to buy equipment and construct an East Greenbush packaging plant known in the industry as a finish-and-fill facility.
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news